Status:
ACTIVE_NOT_RECRUITING
Assessment of Biomarkers in Children to Help Parents Quit Tobacco
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Tobacco Dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized controlled trial will test whether adding biomarker measurement and informed outreach for tobacco smoke exposure as part of routine practice increases identification and improves treat...
Detailed Description
This trial will examine the effectiveness of systematic cotinine testing of children 12 years old or younger using blood already collected at any visit to a practice that sees pediatric patients where...
Eligibility Criteria
Inclusion
- Child 12 years old or younger presenting for a visit.
- Child scheduled for or has had a clinically indicated blood draw at that visit
- Parent/legal guardian of the child.
- Parent/legal guardian is a current smoker (past 7 days).
Exclusion
- Parent/legal guardian is non-English speaking.
- Parent/legal guardian is less than 18 years of age.
Key Trial Info
Start Date :
January 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2026
Estimated Enrollment :
865 Patients enrolled
Trial Details
Trial ID
NCT04832659
Start Date
January 20 2023
End Date
February 28 2026
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MetroHealth System
Cleveland, Ohio, United States, 44109